































Revisão: As complicações neurológicas são um risco importante da cirurgia cardíaca e o 
acidente vascular cerebral (AVC) ocorre em cerca de 2% de todos os procedimentos de 
revascularização do miocárdio. As causas de AVC pós-operatórias são multifactoriais e 
ainda não é totalmente compreendido o papel da doença carotídea no risco da cirurgia 
cardíaca. A cirurgia cardíaca e carotídea síncrona é um procedimento realizado em 
vários centros, em doentes selecionados com múltiplas co-morbilidades. Objetivos: (1) 
Analisar a segurança da cirurgia síncrona, quando efectuada por uma equipa experiente, 
em doentes de alto risco cirúrgico; (2) Comparar a mortalidade e risco de AVC entre 
doentes com diferentes graus de estenose, ou que fizeram cirurgia com circulação 
extracorporal ou off-pump; (3) Avaliar o Euroscore enquanto método estimativo de 
prognóstico em doentes submetidos a cirurgia cardíaca. Métodos: Um estudo 
retrospectivo foi conduzido, incluindo dois grupos dum total de 217 doentes submetidos 
a cirurgia carotídea e cardíaca síncrona, entre os anos 2000-2017 no Hospital de Santa 
Maria, em Lisboa. A análise estatística foi realizada com recurso a Fisher test ou teste 
do qui-quadrado e Mann-whitney test. Resultados: No total, apenas 1 doente (0.46%) 
teve um AVC ipsilateral 24 horas após a cirurgia. Quatro doentes (1.84%) sofreram um 
AVC isquémico ou hemorrágico no hemisfério contralateral ou no cerebelo, sendo a 
taxa de mortalidade global de 7.83%. Não foi registada uma diferença estatisticamente 
significativa na taxa de mortalidade (p=0.524) entre doentes com diferentes graus de 
estenose. Não foi registada uma diferença estatisticamente significativa na taxa de 
mortalidade (p=0.521) entre os doentes que fizeram cirurgia com circulação 
extracorporal ou off-pump. Constatou-se um aumento estatisticamente significativo na 
mortalidade (p=0.0041) e no risco de complicações major (p=0.0006) com o aumento 
do Euroscore. Conclusões: A cirurgia síncrona, efectuada por uma equipa experiente, 
tem um risco neurológico baixo, mesmo em doentes Euroscores elevados. A extensão 
da doença carotídea entre os grupos estudados não teve influência no resultado 
cirúrgico. 
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Background: Neurologic complications remain an important risk of cardiac surgery, as 
stroke occurs in about 2% of all myocardial revascularization procedures. The causes of 
post-CABG stroke are multifactorial and it is not fully understood whether the presence 
of concomitant severe carotid disease increases the risk of the cardiac procedure. 
Several strategies have been attempted, and the synchronous carotid and cardiac surgery 
is a procedure that is frequently performed worldwide in patients with multiple co-
morbidities. Objectives: (1) To analyse the safety of the synchronous surgery, when 
performed by an experienced team, in high-risk patients; (2) To compare the mortality 
and the risk of stroke between patients with different degrees of stenosis or undergoing 
on surgery with extracorporeal circulation and off-pump; (3) To evaluate the Euroscore 
as a tool to establish the prognosis of patients undergoing cardiac surgery. Methods: A 
retrospective study was conducted, including two groups of a total of 217 patients, with 
different degrees of stenosis, undergoing synchronous cardiac and carotid surgery, 
between the years 2000-2017 in Hospital Santa Maria, Lisbon. The statistical analysis 
was performed using a Fisher test or a χ2 test and a Mann-whitney test. Results: Overall, 
only 1 patient (0.46%) has suffered an ipsilateral stroke 24 hours after the procedure. 
Four patients (1.84%) had suffered an ischemic or haemorrhagic stroke on the 
contralateral hemisphere or on the cerebellum and the global mortality rate was 7.83%. 
We have not registered a significant difference in the mortality rates (p=0.524) between 
patients with different degrees of stenosis. There is no significant difference in the 
mortality rates (p=0.521) in patients undergoing surgery with extracorporeal circulation 
and off-pump. There is an increasing risk of death (p=0.0041) and risk of major 
complications (p=0.0006) in patients with higher Euroscores. Conclusions: The 
synchronous surgery, performed by an experienced team, has a very low neurological 
risk, even in patients with high Euroscore levels and significant co-morbidities. The 
extension of the carotid disease among the groups we have studied did not have 
different significant outcomes.  
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Neurologic complications remain an important risk of cardiac surgery and the several 
strategies that were introduced to reduce its incidence were not fully effective. The 
incidence of stroke after coronary artery bypass grafting (CABG) surgery is around 2% 
but it rises to 5-8% when valvular replacement is added (1). Interestingly, most strokes 
after cardiac surgery are delayed and 62% were found to appear more than 24 hours 
after the procedure. The causes of post-CABG stroke are multifactorial and, since the 
typical patient has advanced atherosclerotic disease, some of them will also present with 
severe carotid disease. Approximately 17% of patients undergoing myocardial 
revascularization are noted to have moderate to severe carotid artery stenosis (2) (CAS), 
while 28% have significant coronary artery disease and may be candidates for carotid 
endarterectomy (CEA)(3). The optimal management of the patients requiring cardiac 
surgery with concomitant severe carotid disease remains a controversy.  
A significant number of systematic reviews (4, 5, 6, 7, 8, 9) have previously concluded that 
carotid disease is an important cause of stroke after cardiac surgery and they were 
unanimous in developing an evidence-based strategy for recommending prophylactic or 
combined CEA/CABG. However, evidence suggests that much of the data supporting a 
role for prophylactic intervention may be open to debate. It is still a matter of 
discussion, for instance, whether these outcomes are centred in symptomatic patients or 
are also seen in asymptomatic cases, and enough data is not available for conclusions at 
this moment.  
The purpose of this study is to evaluate and share the experience of a working group of 
a tertiary centre in the treatment of a group of patients, with concomitant cardiac and 
carotid disease, undergoing synchronous carotid and cardiac surgery. We compared the 
outcomes for patients who were symptomatic and asymptomatic, and had different 
degrees of stenosis. We intend to provide as much information as possible regarding the 
patients’ outcomes and to compare their mortality and neurological morbidity rates to 
the data published in the literature, demonstrating that this is a low-risk procedure in 
patients with advanced co-morbidities. We have used the Euroscore to evaluate the 




MATERIAL AND METHODS 
Patient Population 
Since the year 2000, asymptomatic and symptomatic patients, who underwent on 
cardiac surgery and had an underlying severe carotid disease, were scheduled to have 
synchronous cardiac and carotid surgery at Hospital Santa Maria, Lisbon. We have 
retrieved the patients’ indication for cardiac surgery, their demographic data, risk 
factors for atherosclerosis, Euroscore, degree of stenosis and the use of extracorporeal 
circulation from our vascular registry, from our vascular registry. 
For purposes of definition, multi-organ failure, pneumonia, renal failure, perioperative 
bleeding, cervical haematoma, acute myocardial infarction, cardiogenic shock, 
mediastinitis and stroke, which involved hospitalization for more than five days in the 
Intensive Care Unit (ICU), were all regarded as major complications. Patients with 
previous history of stroke, amaurosis fugax or transient ischemic accident were regarded 
as symptomatic patients. 
In order to investigate the role of carotid disease in the surgical outcomes, we have 
analysed the risk of death and the risk of stroke and divided the patients into two 
groups: Group 1 – patients with ipsilateral internal carotid artery stenosis >70% and 
contralateral internal carotid artery stenosis <70%; Group 2 – patients with bilateral 
internal carotid artery stenosis >70% or ipsilateral stenosis >70% and contralateral 
occlusion. The degree of stenosis was calculated using eco-doppler imaging by 
experienced vascular surgeons and technicians from the vascular and neurology’s 
laboratory. 
The population in this study includes a total of 217 patients submitted to synchronous 
carotid and cardiac surgery. One hundred and fifty-four (71%) are male and sixty-three 
(29%) are female and their mean±SD age is 70.91±10.39 years (52-85). The patients 
have a median Euroscore level of 11.42, which made them accessed as “high-risk 
patients”. 
All patients were operated on the Cardiothoracic Surgery Operating Room in Hospital 
Santa Maria, Lisbon, from 2000 to 2017. 
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Cerebrovascular Disease and Carotid Surgery 
One hundred and eighty-six (85.7%) patients did not have any previous neurological 
symptom and thirty-one (14.3%) were symptomatic, with previous history of stroke 
(23), transient ischemic attack (7) or amaurosis fugax (1) over the past 6 months. 
All patients undergoing carotid surgery had carotid stenosis over 70%. The median 
range of stenosis in the operated carotid artery was 90% (70-95%) (see Table 1). The 
contralateral internal carotid artery presented a median stenosis degree of 50%. Thirteen 
patients (6%) had a complete occlusion of the contralateral internal carotid artery, forty-
four cases (20.3%) had 70-99% stenosis and ninety-seven patients (44.7%) had 50-69%. 
In sixty-three patients (29%), the contralateral stenosis was <50%.  
According to this data, the vascular procedure was indicated by unilateral stenosis 
>70% in one hundred and twenty-four (57.1%) patients, by unilateral stenosis >70% 
associated with contralateral stenosis 60-69% in thirty-six (16.6%) patients, by bilateral 
stenosis >70% in forty-four (20.3%) patients and finally by unilateral stenosis >70% 
associated with contralateral occlusion in thirteen (6%) patients (see Table 1). 
The carotid procedure was performed immediately before the sternotomy and always by 
the same vascular surgeon (LMP). The carotid procedure included two-hundred and 
four (94%) cases of conventional endarterectomy (CEA), nine (4%) cases of eversion 
CEA, two (1%) cases of venous interposition between the common carotid artery and 
the internal carotid artery and two (1%) cases of ascending aorta to carotid bifurcation 
or innominate artery bypass. The CEA was closed with patch (venous in two-hundred 
cases – 98%, and Dacron in four cases – 2%). Anticoagulation with non-fractioned 
heparin IV in a dose of 2000-2500 units was always administered before carotid 
clamping. A shunt during the carotid clamping period was inserted according to the 
residual pressure criteria (shunt if residual pressure < 50 mmHg). Shunting was used in 
seventy-five (34.6%) cases (Pruitt-Inahara in 70 and Javid in 5).  
The cervical incision was always closed at the end of the carotid procedure in all but 






Cardiac procedure: The cardiac surgery was performed by isolated valvular disease, 
isolated severe coronary disease or combined with valvulopaty, left-ventricular 
aneurism or auricular mixoma. CABG, single or multiple, was performed in one-
hundred and thirty-nine cases (64.1%), CABG associated with valvular replacement in 
forty-six cases (21.2%), CABG associated with pericardiectomy in one case (0.5%), 
CABG associated with ventricular aneurismectomy in one case (0.5%), CABG 
associated with a pacemaker implantation in one case (0.5%) and CABG associated 
with a mixoma resection in one case (0.5%). In twenty-six cases (12%), isolated 
valvular replacement was performed. Extra-corporeal circulation was used in sixty-nine 
cases (31.8%), while in one-hundred and forty-eight cases (68.2%) the surgery was 
performed off-pump (see Table 1). 
 
Statistical Analysis 
Continuous variables were expressed as mean±SD if symmetrically distributed and 
comparison was made by t-student test. Asymmetrical distribution continuous data were 
expressed as median (range) and compared with Mann-Whitney test. Categorical data 
were summarized as frequencies and percentages and compared using the Fisher exact 
test. Multivariate logistic regression analysis was performed to control for confounders.  


























Table 1: Demographic data. 		 		
  n % 
All patients 217   
Male 154 71 
Female 63 29 
 
Symptoms 	 		
Symptomatic 31 14.3 
- Stroke 23 		
- TIA 7 		
- Amaurosis fugax 1 		
Asymptomatic 186 85.7 
 
Carotid disease: 	 		
HOMOLATERAL 	 		
70-79% 16 7.4 
80-89% 85 39.2 
90-99% 116 53.4 
CONTRALATERAL 	 		
<50% 63 29 
50-59% 61 28.1 
60-69% 36 16.6 
70-79% 21 9.7 
80-89% 15 6.9 
90-99% 8 3.7 
Occlusion 13 6 
		 	 		
Unilateral >70% 124 57.1 
Unilateral >70% + 
Controlateral 60-69% 36 16.6 
Bilateral >70% 44 20.3 
Unilateral >70% + 
Controlateral occlusion 13 6 
 
Cardiac procedure: 	 		
CABG 139 64.1 
CABG+pericardiectomy 1 0.46 
CABG+ valvular replacement 46 21.2 
CABG+ventricular 
aneurysmectomy 1 0.46 
CABG+pacemaker 1 0.46 
CABG+Mixoma resection 1 0.46 
Isolated valvular replacement 26 12 
Unkown 2 0.92 
		 	 		
CBP 69 31.8 




Table 2 presents the results of this series 30 days after the procedure. 
Overall, of the total 217 patients, none of the patients had an intra-operatory stroke. 
However, one patient (0.46%) has suffered an ipsilateral stroke 24 hours after the 
procedure. Four patients (1.84%) had suffered an ischemic or haemorrhagic stroke on 
the contralateral hemisphere or on the cerebellum (see Table 2). The overall mortality 
rate was 7.83% (17 deaths). 
We registered thirteen deaths (8.1%) from Group 1 and four deaths (7%) from Group 2. 
One patient (1.75%) from Group 2 suffered an ipsilateral stroke 24 hours after the 
procedure. Two patients (1.3%) from Group 1 and two patients (3.5%) from Group 2 
suffered an ischemic or haemorrhagic stroke on the contralateral hemisphere or on the 
cerebellum, and all of them have died.  
The overall mortality rates between the two groups was not significantly different 
(p=0.524), neither was the risk of any stroke (p=0.282).  Group 1 had 14.0% (eight 
patients) of major complications and group 2 had 21.3% (thirty-four patients), with no 
significant difference between the two groups (p=0.161). 
A slightly lower mortality rate, still not statistically significant (p=0.521), was observed 
when using extracorporeal circulation (7.2% versus 8.1%)	
 
EUROSCORE 
Median Euroscore was higher among the patients who died (12.74) than the patients 
who survived (8.21) (p=0.0041). Patients who have suffered post-operative major 
complications had a higher Euroscore median value (11.49 versus 7.86, p=0.0006). 
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n (%) n (%) n (%) n (%) n (%) 
All patients 217 17 (7.83) 1 (0.46) 4 (1.84) 17 (7.83) 17 (7.83) 
Male 154 10 (6.5) 1 (0.65) 4 (2.6) 10 (6.5) 10 (6.5) 
Female 63 7 (11,1) 0 0 7 (11,1) 7 (11,1) 
         
Symptomatic 31 3 (9.7) 1 (3.2) 2 (6.4) 3 (9.7) 3 (9.7) 
Asymptomatic 186 14 (7.5) 0 2 (1.1) 14 (7.5) 14 (7.5) 
  	 	 	 	 	 		
Carotid disease: 
Group 1 (Ipsilateral 
>70% + 
Contralateral <70%) 
160 13 (8.1%) 0 2 (1.3%) 13 (8.1%) 13 (8.1%) 
Group 2 (Bilateral 





57 4 (7%) 1 (1.75%) 2 (3.5%) 4 (7%) 4 (7%) 
Cardiac procedure: 	 	 	 	 	 		
CABG 139 14 (10.1) 1 (0.7) 4 (2.9) 14 (10.1) 14 (10.1) 
CABG + 
pericardiectomy 1 0 0 0 0 0 
CABG + ventricular 
aneurysmectomy 1 0 0 0 0 0 
CABG + pacemaker 1 1 (100) 0 0 1 (100) 1 (100) 
CABG + mixoma 
resection 1 0 0 0 0 0 
CABG + valvular 
replacement 46 1 (2.2) 0 0 1 (2.2) 1 (2.2) 
Isolated valvular 
replacement 26 1 (3.8) 0 0 1 (3.8) 1 (3.8) 
Unknown 2 0 0 0 0 0 
		 	 	 	 	 	 		
CBP 69 5 (7.2) 0 1 (1.4) 5 (7.2) 5 (7.2) 




Stroke remains a serious complication of cardiac surgery and it occurs in about 2% of 
all myocardial revascularization procedures. It is not yet clear whether the presence of 
significant carotid disease is an important incremental risk factor for the development of 
stroke after CABG. A recent updated systematic review and meta-analysis has reported 
outcomes in patients with severe CAS (70–99% stenosis) or occlusion, undergoing an 
isolated cardiac procedure, and the prevalence of stroke, death and death/stroke was 
7.4%, 4.8% and 6.5%, respectively (10). Several studies have shown that carotid disease 
is an important aetiological factor in the pathophysiology of post-CABG stroke (11), 
considering that the presence of an unilateral carotid stenosis >50% raises the 
neurological risk to 3%, the presence of bilateral stenosis >50% raises the risk to 5% 
and when there is contralateral occlusion of the internal carotid artery, the risk of an 
intra-operative stroke is about 7-11% (12, 13). These data suggest that the treatment of an 
underlying carotid lesion might help to reduce the incidence of stroke, which lead to the 
introduction of several therapeutic strategies, such as a staged CEA followed by cardiac 
surgery or, more recently, at the same operating time – the synchronous surgery. 
Furthermore, in the general CABG population, the prevalence of significant CAS is 
relatively high. The reported prevalence of moderate CAS (more than 50% stenosis) is 
around 22% (14), which results in a 3.8% stroke rate (15), and the prevalence of severe 
CAS (more than 80% stenosis) is around 8.5% (14), resulting in a 14% stroke rate (16). 
Additionally, the risk of perioperative stroke in CABG patients who reported a prior 
TIA or stroke has been associated with a fourfold increased risk as compared to the risk 
for asymptomatic patients (17). However, most of these studies did not determine 
whether overall cardiovascular risk of death, stroke or myocardial infarction – usually 
estimated by the Euroscore – are increased in patients with severe carotid and coronary 
disease undergoing CABG. On the other hand, there are studies suggesting that there is 
no direct causal relationship linking postoperative stroke and severe carotid stenosis. 
Some authors claim that there is a failure to establish a connection between the strokes 
and the diseased carotid territories raising the hypothesis that these postoperative 
strokes may be attributable to alternate causes (18). In a retrospective analysis of 878 
patients who underwent on isolated CABG, there was no significant difference in the 
mortality rates and in the neurological outcomes between patients with severe CAS 
(defined in this study as >75% stenosis) and patients without severe CAS (20). A 
retrospective review by Adams et al. identified 1,499 patients who underwent cardiac 
	 15	
surgical procedures between July 1999 and September 2010 and concluded that most 
perioperative strokes after cardiac surgery procedures do not arise from carotid lesions 
but are more likely caused by atheroemboli from arch manipulation, global 
hypoperfusion associated with low cardiac output, or other causes. They have 
established that universal carotid artery screening in cardiac surgery patients has not led 
to a decreased incidence of strokes in the patient population and only few strokes can be 
directly linked to carotid lesions (21). In a smaller study of 139 patients with severe 
(>75% stenosis), unilateral, asymptomatic CAS undergoing CABG, with a group of 73 
patients having no carotid artery surgery and a group of 66 patients having staged CEA, 
Gaudino et al (22) reported no differences between the in-hospital rates of stroke (0% 
versus 0%; P=1.0) or mortality (1.4% versus 1.5%; P>0.05). In a series of 50 patients 
with asymptomatic CAS >70% undergoing CABG without prophylactic CEA, Ghosh et 
al (23) demonstrated no adverse cerebrovascular incident within 30 days postoperatively, 
and only 1 experienced a transient ischemia attack at 14 months. Overall, this data 
represents only a fraction of data compared to the vast amount of previous information 
demonstrating a high stroke incidence (9.2–11.5%) in isolated CABG, and also describe 
different patient populations (off or on-pump bypass surgery, asymptomatic or 
symptomatic patients) (24).  
The 2014 European Society of Cardiology’s guidelines for myocardial revascularization 
state that the prevalence of severe carotid artery stenosis increases with the severity of 
coronary artery disease and is an indicator of impaired prognosis. As so, in patients with 
previous TIA or stroke and the presence of carotid artery stenosis (50–99% in men; 70–
99% in women), CEA performed by experienced teams may reduce the risk of 
perioperative stroke or death. Carotid revascularization may be considered in 
asymptomatic men with bilateral severe carotid artery stenosis or contralateral 
occlusion, provided that the risk of stroke or death within 30 days can be reliably 
documented to be <3% in the presence of a life expectancy >5 years. In women with 
asymptomatic carotid disease or patients with a life expectancy of <5 years, the benefit 
of carotid revascularization remains unclear. Conversely, isolated myocardial 
revascularization should be performed among patients with asymptomatic unilateral 
carotid artery stenosis because of the small risk reduction in stroke and death achieved 
by concomitant carotid revascularization (1% per year) (25, 26). 
In our study, we have tested two different groups of patients and we did not find a 
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statistical significant difference between the group of patients with ipsilateral severe 
CAS (>70%) and contralateral CAS <70% (Group 1) and patients with bilateral severe 
CAS (>70%) or ipsilateral severe CAS and contralateral occlusion. The mortality and 
morbidity rates on both groups were low and agreed to previous studies (8.1% deaths + 
stokes on Group 1 vs 7% deaths + strokes on Group 2, p=0.524). The risk of any stroke 
was also low and not statistically different on both groups (1.3% in Group 1 and 3.5% 
in Group 2, p=0.282). 
The incidence of stroke may also be related to the cardiopulmonary bypass, and whether 
off-pump CABG reduces the evidence of stroke remains controversial. Two large meta-
analysis agreed that the benefit of off-pump coronary artery bypass surgery in reducing 
the incidence of stroke is marginal (27, 28), however, according to a retrospective study 
of 16.184 patients, the incidence of stroke is shown to be significantly lower with off-
pump CABG (2.5%) than with conventional CABG (3.9%) (29). More recently, Lamy et 
al. concluded that at 1 year, in a group of 4752 patients scheduled to undergo CABG, 
there was no significant difference in the rate of the primary composite outcome 
between off-pump and on-pump CABG (12.1% and 13.3%, respectively), the rate of 
repeat coronary revascularization, quality of life, or neurocognitive function (30). Our 
study shows that the mortality rate on patients undergoing conventional and off-pump 
CABG has no statistical difference (7.2% and 8.1%, p=0.521, respectively), even when 
controlled with Euroscore (p=0.409), which correlates with recent data. 
Recent randomized controlled trials have attested the safety and efficacy of the 
synchronous carotid and cardiac procedure in patients with severe CAS with 
concomitant coronary disease (31, 32). In a retrospective study with 3700 patients, on 
which 47 patients were taken for simultaneous CEA and CABG and none of them has 
suffered from ischemic stroke, myocardial infarction or death during the perioperative 
period, the synchronous procedure was considered to be safe and effective. Other 
systematic reviews and meta-analysis, and our own experience, all favour combined 
surgery as a safe option in cases of severe CAS undergoing CABG (11, 33, 34). Recent 
studies have suggested comparable outcomes in the staged and combined approach, 
without any advantages of one technique over the other, and concluded that patient 
specific risk factors and morphology of the atherosclerotic disease might be more 
important determinants of postoperative morbidity and mortality rather than the 
therapeutic strategy (35). Recent data states that, although patients undergoing combined 
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CEA and CABG had higher preoperative risk factors, the combined approach was 
performed with comparable rates of mortality and major cardiovascular morbidity in the 
early postoperative period (36). 
Our study demonstrates that the synchronous CEA and CABG is a safe procedure, with 
favorable outcomes, and that does not sustain a higher perioperative mortality rate. We 
have performed this procedure in a group of 217 patients, throughout the past seventeen 
years with the same vascular team, and our strategy was associated to a very low risk of 
ipsilateral perioperative stroke (1 patient, 0.46%) and a very low risk of perioperative 
stroke overall (4 patients, 1.84%). Our mortality rate was 7.83% (17 patients), but most 
of all deaths were related to other comorbidities of the patient. CEA seemed to 
contribute to decrease the rate of ipsilateral stroke to residual levels. However, as 
expected, it had no impact in contralateral and vertebrobasilar stroke and consequently 
in the overall stroke risk. 
Overall, the patients included in our study we high risk and had a mean Euroscore level 
of 11.42, and the patients who have died have a mean Euroscore level of 12.74. There is 
a significant difference (p=0.0041) in the Euroscore level between the patients who 
have died and those who have survived and between the patients who suffered major 
complications and those without surgical complications (p=0.001). This means that, as a 
group, patients with carotid stenosis suffer from other comorbidities that influence the 
high Euroscore observed and also that mortality seems to be related to the associated 
diseases and the general medical frailty. This is in consonance to the publications that 
demonstrate a higher atherosclerotic burden in patients with cerebrovascular disease (21, 
32, 37, 38). 
Limitations: We encountered some limitations in the data collected for this study, 
which reflect both record keeping by clinicians as well as the current state of the 
medical record system. First, a few operative notes lacked details concerning the extent 
and location of coronary and carotid artery disease. Second, since this was a 
retrospective study, some data was not clear in older folders, which made our evaluation 
harder and it was not possible to add all the variables we wanted to study since we have 
lost contact to most of the oldest patients and did not have their discharged papers or 
information about subsequent consults. Third, patients often did not have a detailed 
neurological evaluation, which might have provided further understanding of both their 
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symptoms and extent of nervous system involvement. Fourth, radiological reports often 
did not describe in sufficient detail the involved cerebral circulation, which might 
account for a portion of the unclassified strokes. Fifth, we did not have a control group, 
which made it harder to define our variables. 
Despite these limitations, we are confident that our findings are in agreement with the 
peer-reviewed literature. We have no reason to believe that these limitations severely 
hampered our ability to make our conclusions. 
In conclusion, our study showed that the synchronous surgery, performed by an 
experienced team, did not incur excess risks, compared with staged interventions. The 
degree of stenosis seems not having an impact in the risk of stroke or death. However, 
the Euroscore is related to the overall risk of death in this group of patients and it is safe 
to assume that patients with higher risk factors for cardiac surgery (higher Euroscore) 
will be on higher risk of mortality and post-operative complications, irrespectively of 
being submitted to concomitant carotid revascularization, which seemed to had a 
positive impact in the prevention of ipsilateral stroke.	
Further studies are needed in order to unequivocally prove that CEA does not add 













Os desfechos neurológicos mantêm-se como um comum factor de complicação Da 
cirurgia cardíaca e as diversas tentativas de diminuir a sua incidência não foram 
totalmente eficazes. Os principais factores de risco são cardioembólicos, 
ateroembólicos, hemodinâmicos, e hemorrágicos.  
A incidência de Acidente Vascular Cerebral (AVC) após Cirurgia de Revascularização 
do Miocárdio (CRM) é cerca de 2% e aumenta para 5-8% quando é acrescentado um 
procedimento de substituição de válvula. Cerca de 17% dos doentes que fazem CRM 
têm doença carotídea moderada a grave, sendo que 28% são candidatos a 
endarterectomia. A presença de estenose carotídea unilateral >50% aumenta o risco de 	
complicações neurológicas para 3%, a presença de estenose carotídea bilateral >50% 
para 5% e a oclusão contralateral da artéria carótida interna para um risco de AVC intra-
operatório de 7-11%, o que sugere que a presença de doença carotídea e a sua gravidade 
são determinantes do risco de complicações neurológicas associadas à cirurgia cardíaca. 
O melhor método para tratar doentes candidatos a cirurgia cardíaca com doença 
carotídea grave concomitante mantém-se incerto e gera controvérsia. 
A cirurgia carotídea e cardíaca síncrona é um procedimento extensamente utilizado e 
estudado em vários centros mundiais e pode diminuir o risco e a incidência de 
complicações neurológicas em doentes com múltiplas co-morbilidades que são 
submetidos a cirurgia cardíaca. O objectivo desta investigação é analisar o risco-
benefício da utilização desta cirurgia em doentes de alto risco cirúrgico e apresentar a 
experiência do Hospital de Santa Maria durante os anos de 2000-2017, onde mais de 
217 doentes foram operados. 
A população em estudo engloba 217 doentes, 71% do sexo masculino e 29% do sexo 
feminino, com uma idade média de 70.91 anos e um Euroscore médio de 11.42. 14.3% 
dos doentes tinham antecedentes pessoais de AVC, Acidente Isquémico Transitório 
(AIT) ou Amaurose Fugaz, sendo classificados como “sintomáticos”, enquanto que 
85.7% eram assintomáticos. No sentido de estudar o papel da doença carotídea nos 
resultados cirúrgicos, analisou-se o risco de AVC e morte dividindo a população em 2 
grupos: Grupo 1- doentes com estenose carotídea unilateral >70% e contralateral <70%, 
e Grupo 2- doentes com estenose carotídea bilateral >70% ou com estenose unilateral 
>70% e oclusão contralateral. Todos os doentes submetidos a endarterectomia 
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convencional (CEA) tinham um grau de estenose superior a 70%. A CEA foi realizada 
em 94% dos casos, em 4% dos casos foi realizada CEA de eversão, em 1% interposição 
venosa entre a artéria carótida interna e a artéria carótida comum e em 1% interposição 
venosa entre a aorta ascendente e a bifurcação carotídea. A CEA foi fechada com patch 
venoso em 98% dos casos. Foi usada uma dose de Heparina Não-Fraccionada 
endovenosa (2000-2500UI) antes da clampagem da carótida. Foi realizado shunt 
durante a clampagem da carótida sempre que a pressão residual era <50mmHg. A 
incisão cervical foi encerrada em todos os casos após o final do procedimento carotídeo, 
excepto num caso em que as condições de hemostase não era adequadas. A cirurgia 
cardíaca foi realizada por doença valvular isolada, doença coronária isolada ou 
combinada com valvulopatia, aneurisma ventricular esquerdo ou mixoma auricular. Foi 
realizada circulação extra-corporal em 31.8% dos casos e a cirurgia foi realizada off-
pump em 68.2% dos casos. A tabela 1 apresenta todos os dados demográficos da 
população em estudo. 
Relativamente aos resultados obtidos, de realçar que não ocorreu nenhuma morte peri-
operatória, houve apenas 1 AVC ipsilateral após 24 horas da cirurgia e, no total, 
morreram 4 doentes com AVC isquémico ou hemorrágico no hemisfério contralateral 
ou no cerebelo. A taxa de mortalidade global foi de 7.83%. Em relação aos doentes do 
grupo 1, houve uma taxa de mortalidade de 8.1%, dos quais 1 AVC cerebelar e 1 AVC 
do hemisfério contralateral, enquanto que no grupo 2 a taxa de mortalidade foi 7%, 
tendo ocorrido 1 AVC ipsilateral e 1 AVC do hemisfério contralateral. A mortalidade 
foi ligeiramente inferior nos doentes com circulação extra-corporal, embora não 
estatisticamente significativa (p=0.521). O Euroscore médio entre os doentes que 
tiveram complicações pós-operatórias era maior (p=0.0006), assim como entre os 
doentes que morreram (p=0.0041). A tabela 2 apresenta os resultados cirúrgicos após 30 
dias. 
A literatura existente sugere que o grau de estenose carotídea e a gravidade da doença 
carotídea estão relacionadas com o aumento da mortalidade por complicações 
neurológicas no decorrer e após cirurgia cardíaca, pelo que o tratamento da doença 
carotídea de base poderá fazer diminuir a incidência de AVC na CRM. Por outro lado, 
revisões sistemáticas recentes objectivam que outros factores de risco são mais 
determinantes para esses desfechos neurológicos, como os antecedentes pessoais de 
AVC e AIT, comparando-os com doentes assintomáticos. As guidelines actuais da 
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Sociedade Europeia de Cardiologia e da Sociedade Europeia de Cirurgia Vascular são 
unânimes a considerar que, actualmente, não existe uma estratégia eficaz e consensual 
para o tratamento de doentes de alto risco cirúrgico com doença carotídea grave 
concomitante, deixando ao critério da equipa experiente a análise de cada doente 
individualmente. A única indicação prende-se com uma história pessoas de AVC ou 
AIT nos 6 meses anteriores à cirurgia cardíaca, em doentes com estenose da artéria 
carótida interna superior a 70%, na qual há uma indicação clara para a CEA. O próprio 
timing da CEA é alvo de estudo e debate, sendo que múltiplos estudos comprovaram a 
segurança do procedimento síncrono, às vezes até superior, quando comparado ao 
procedimento escalado. De acordo com os nossos resultados obtidos, não encontramos 
diferenças estatisticamente significativas tanto na taxa de complicações major 
(determinadas pela ocorrência de falência multi-orgânica, enfarte agudo do miocárdio, 
choque cardiogénico, pneumonia, mediastinite, lesão renal aguda e hematoma cervical, 
que tivesse implicado uma estadia na Unidade de Cuidados Intensivos superior a 5 dias) 
quanto na taxa de mortalidade global nos dois grupos de estudo (8.1% de AVC+morte 
no grupo 1 versus 7% no grupo 2, p=0.524). Mesmo no grau de gravidade da doença 
carotídea, não foram encontradas diferenças estaticamente significativas para os 
outcomes neurológicos entre os dois grupos populacionais. Por outro lado, no estudo de 
comparação das complicações major pós-cirúrgicas, observou-se que os doentes que 
tiveram complicações tinham um Euroscore superior aos que não tiveram (11.49 vs 
7.86, p=0.0006), enquanto que entre os doentes que morreram o Euroscore era também 
estatisticamente diferente dos que sobreviveram (12.74 vs 8.21, p=0.0041). Estes dados 
demonstram que os doentes com estenose carotídea têm outras co-morbilidades que 
influenciam o seu Euroscore e que a mortalidade está também relacionada com essas 
doenças de base e com seu estado de saúde precário, o que está em consonância com a 
literatura mais actual. 
Em conclusão, o nosso estudo demonstra que a cirurgia síncrona, quando efectuada por 
uma equipa experiente, não obteve riscos cirúrgicos adversos, comparáveis às 
intervenções escaladas. O grau de estenose não parece ter um impacto significativo na 
taxa de mortalidade e AVC pós-cirúrgicos, contudo o Euroscore, que é bastante elevado 
no nosso grupo de estudo, demonstra que os doentes estão em maior risco de 
complicações, independentemente do tipo e complexidade de cirurgia cardíaca 
realizada. A revascularização carotídea síncrona parece ter um impacto positivo na 
prevenção de AVC ipsilateral.  
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